Deep Recon

Deep Recon utilizes deep learning-based image reconstruction, employing dedicated deep neural networks, to process X-ray transmission data from CT scans, aiming to reduce image noise and improve low contrast detectability. This technology is designed to enhance diagnostic image quality for various anatomical regions in adults, potentially enabling effective imaging at lower radiation doses compared to traditional Filtered Back Projection methods.

Deep Recon is a data-driven image reconstruction method utilizing deep learning technology, designed for use with uCT 760 and uCT 780 computed tomography (CT) systems. Its purpose is to generate cross-sectional images from X-ray transmission data obtained via axial, helical, and cardiac acquisitions. The system employs dedicated deep neural networks (DNNs) trained for various body parts—specifically head, chest, abdomen, cardiac, and vascular applications in adults. The core methodology involves these DNNs processing CT data to produce images with an appearance similar to traditional Filtered Back Projection (FBP) but with enhanced characteristics, aiming to reduce image noise, improve low contrast detectability, and potentially lower the radiation dose required for diagnostic CT imaging. Non-clinical performance testing and clinical image evaluations were conducted to validate Deep Recon. Engineering bench tests, using phantoms and comparing Deep Recon with FBP on the same raw datasets, demonstrated improved low contrast detectability and decreased image noise, while maintaining equivalent mean CT number, uniformity, spatial resolution, and reconstructed section thickness. Retrospective clinical image evaluations, involving board-certified radiologists, indicated that images reconstructed with Deep Recon were of equivalent or superior diagnostic quality compared to FBP. Furthermore, a study showed that low-dose images processed with Deep Recon were diagnostically equivalent or better than standard-dose images reconstructed with FBP, supporting its potential for dose reduction.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific deep neural network architectures are employed for the different anatomical regions (head, chest, abdomen, cardiac, vascular), and how was the training dataset curated to ensure robustness and generalizability across diverse patient populations?; How does the performance of Deep Recon, particularly in terms of low contrast detectability and noise reduction, scale with varying levels of X-ray dose reduction beyond what was compared against standard dose FBP?; What are the quantitative differences in spatial resolution and mean CT number accuracy between Deep Recon and FBP, especially at the lowest achievable doses with Deep Recon?; Are there any specific image textures or potential artifacts introduced by the Deep Recon algorithm that differ from traditional FBP, and how might these affect diagnostic interpretation for subtle pathologies?; Beyond the reader studies on image quality, has there been any evaluation of Deep Recon's impact on diagnostic confidence or inter-reader variability for specific clinical tasks within its intended applications?